THE POSSIBILITY of restoring an adequate supply of blood to the ischemic myocardium has been considerably increased during the past few years, partly because of the development of potent, nontoxic thrombolytic agents' and in part because of improved surgical and angioplastic techniques. However, to what extent, and precisely when, such interventions are beneficial is a matter for debate, since under certain conditions reperfusion appears to jeopardize potentially salvageable myocardium.2
Hearse and Nayler and their colleagues`w ere largely responsible for popularizing the concept of "reperfusion injury" with respect to the heart and during the past decade the occurrence of this phenomenon has been widely investigated, particularly in experiments in which isolated hearts have been reperfused after prolonged periods of normothermic global ischemia. Under these conditions in vitro the quantification of any additional injury associated with reperfusion is relatively easy. The washout of intracellular enzymes and of other macromolecules,2 gross changes in ultrastructure, sustained increases in end-diastolic resting tension, increases in tissue water and calcium, and a failure to exclude extracellular markers and dyes are only a few of the indexes that have been used.4'5 By contrast, the detection and quantification of damage associated with postischemic reperfusion under conditions in vivo is relatively difficult, particularly if the end point involves the measurement of infarct size. Many factors have to be taken into account, including the amount of collateral flow that is present, accompanying hemodynamic changes in the peripheral circulation, and even the precise location and size of the infarct. Even if all of these factors are controlled an From figure 1 ) the ultrastructural changes appear to be relatively benign.5 The sarcoplasmic reticulum may be swollen, glycogen granules are usually absent, and the myofibrils may contain prominent I bands, but they remain in regular array. The nuclei usually exhibit peripheral aggregation of their chromatin and some mitochondrial swelling occurs. Possibly of greater importance is the accumulation of fluid (figure 1) beneath the sarcolemma, which is indicative, as Jennings et al. 5 have suggested, of substantial changes in tissue osmolarity, and which may in turn cause abnormal physical stresses to develop within the cell membrane.
Other changes are beginning to occur at this time. The endogenous stores of noradrenaline are being mobilized.12 The Cat -accumulating activity of the sarcoplasmic reticulum also begins to be impaired. The plasmalemma, although intact and still capable of excluding large macromolecules'0 and retaining intracellular enzymes, shows signs of change. For instance, by this time there is a twofold increase in its a-adrenocep- tor density,13 a change that occurs well ahead of any detectable change in phospholipid content. The failure of investigators to detect significant changes in tissue phospholipid content at this time does not necessarily mean that the membrane phospholipids have remained intact and correctly oriented. To the contrary, the increased levels of lysophosphoglycerides that occur at this time'4`are indicative of increased phospholipase activity and altered phospholipid metabolism.
Extending the period of ischemia beyond 30 min results in further and progressive changes in cell biochemistry and morphology. There is a further accumulation of lysophosphoglycerides,14 ' which is indicative of an accelerating rate of phospholipid and hence membrane degradation. At the same time tissue xanthine oxidase activity increases'6 and the activity of the endogenous free-radical scavengers decreases.17 The resultant accumulation of superoxide radicals will favor lipid peroxidation, leading in turn to a further weakening of the cell membrane and ultimately to a loss of membrane integrity."1&i Hence, even without reperfusion there are at least three factors working in CIRCULATION unison to weaken and disrupt the sarcolemma: physical stress due to changes in tissue osmolarity,5 phospholipid degradation and reorientation,14' 15 and lipid peroxidation, associated with the accumulation of free radicals. 1S1
As far as the morphology of the tissue is concerned, peripheral reaggregation of the nuclear chromatin now becomes a prominent feature. Cell swelling becomes more evident, as does swelling of the mitochondria and sarcoplasmic reticulum. After 60 min or more of ischemia discontinuities in the plasmalemma are readily detected.5 If these discontinuities are not fixation artifacts, then their occurrence probably signals the ultimate death of the cell, since they will permit the free diffusion of macromolecules, water, and electrolytes across what was once a semipermeable barrier. Under these conditions therefore, and even if "protective" procedures are now introduced, reperfusion, with its attendant reintroduction of unlimited supplies of 02 and Ca+ +, can only hasten cell death. At the same time it will facilitate the expression of the lethal damage that was sustained during the preceding period of ischemia.
The picture presented so far is misleading in at least one important aspect. The time-dependent progression of ischemic damage has been stressed, but one significant facet of the response has been ignored; that is, its heterogeneity. At any one time it is possible to find cells that exhibit all the characteristics of ischemic damage, including sarcolemmal discontinuities, swollen mitochondria, glycogen depletion, and margination of nuclear chromatin, closely adjacent to relatively normal cells, as judged by their ultrastructural appearance. This heterogeneity is particularly evident when transmural sections are used to quantitate the ischemia-induced damage, with the endocardium showing earlier changes in ultrastructure relative to the epicardium.
The importance of the preparation. The data that have been referred to so far have been obtained largely from experiments on isolated, globally ischemic hearts. Other investigators have used different preparations, including low-flow rather than global ischemia. Some have used coronary artery ligation to produce regional (rather than global) ischemia in isolated and in situ hearts. Alternatively, isolated intraventricular septa'0 and papillary muscles5 have been made "ischemic" by placement in humidified, temperature-controlled chambers gassed with nitrogen, or simply evacuated. In each case the end result is irreversible injury, but with markedly differing time courses. For example, during conditions of low-flow ischemia plasmalemmal discontinuities appear within about 30 min, possibly because of the continued, although slowed, supply of Ca +, 02, and H20 in the perfusate. By contrast, under conditions of global ischemia plasmalemmal discontinuities are a relatively late event. Clearly differences such as this make the comparison of data obtained from different preparations hazardous, particularly with respect to the time course of the progression from reversible to irreversible injury.
Special mention perhaps should be made of two preparations that, in our opinion, are incorrectly equated with those used to study the effects of ischemia and reperfusion. One of these involves the use of hypoxia rather than ischemia. Although, as with ischemia, there is a rapid depletion of the endogenous reserves of ATP and PC during hypoxic perfusion, hypoxia differs from ischemia with respect to the rate of removal of metabolic byproducts, including protons. Moreover, Ca'+ and 02 continue to be present in the extracellular fluid. The second preparation involves the readmission of Ca+ + after a period of Ca+ +-free perfusion -the "'calcium paradox." Under these conditions, as during postischemic reperfusion, massive Ca+ + overloading occurs, but in the former case, and not the latter, uncontrolled Ca + gain occurs despite normal (or even raised) levels of ATP and PC at the onset of repletion. Even the ultrastructural damage induced by the calcium paradox differs from that caused by postischemic reperfusion.
The reperfused myocardium. As stated above, reperfusion after relatively short periods of ischemia ultimately results in the recovery of the affected area, although the recovery may be delayed. 8 From the outset it is clear that the reperfusion of already lethally injured tissue will result in an apparent exacerbation of the damage, but the cells have already been lethally injured. The important and as yet unresolved question relates to the effect of reperfusion of tissue that, although not yet lethally injured, is damaged. Under these circumstances it is possible for reperfusion to be either beneficial or deleterious. Some laboratory data show that if the composition of the reperfusion buffer is suitably adjusted (by changing its Ca ++ or Na+ content,9' 20 or adding free-radical scavengers21 22 or metabolic precursors to ensure the rapid recovery of purine precursors for ATP synthesis11), then reperfusion, even if it occurs after prolonged periods of ischemia, can result in a sustained increase in functional and metabolic recovery. Under these conditions reperfusion can be regarded as being beneficial, presumably because the tissue is able to maintain homeostasis despite the reintroduction of an unlimited supply of 02 and Ca`. Sharma et al.23 have shown that nonlethally injured cells can gain Ca+ + on reperfusion without precipitating structural alterations equated with cell death. However, once the cells lose their capacity to maintain homeostasis, and the cellular Ca+ + content exceeds a critical level, the destructive chain of events summarized in figure 3 cannot be reversed.
That Ca`+ plays a prominent role3' 19, 24 in the cascade of events that terminates in irreversible injury under these conditions is no longer a matter for debate.
Nor is there any doubt that the Ca`+ that is involved is of extracellular origin. What is surprising, however, is that its route of entry has not yet been clearly defined.
Since massive Ca`+ overloading can occur in the absence of sarcolemmal discontinuities,24 it is possible that some of the early gain in Ca+ + is due to failure to expel Ca' + that has entered through normal physiologic pathways. 4 The free inward diffusion of Ca`+ through membrane discontinuities would then represent a secondary process that is preceded by whatever physical and biochemical events were responsible for fragmenting the membrane.
In summary, therefore, reperfusion with 02 and Ca+ +-containing solutions of tissue that is already lethally injured, instead of being beneficial, will hasten the expression of the lethal injury and in so doing precipitate cell death. By contrast, the reperfusion of tissue that, although damaged, is not yet lethally injured, can either facilitate its recovery or precipitate lethal injury. Which of these two alternatives applies depends largely on the amount of injury already sustained as well as on the composition of the reperfusion buffer. The first alternative is probably applicable to situations in which cells in the affected region are still capable of controlling free-radical generation, of maintaining homeostasis with respect to Ca , and of replenishing their endogenous energy-rich phosphate reserves. If, on the other hand, the ischemia-but not yet lethally injured tissue has already lost its capacity to regenerate energy-rich phosphates, to control freeradical generation, and to maintain ionic and osmotic homeostasis, then reperfusion with 02 and Ca`+ -containing buffers will facilitate the transition from nonlethal (and hence reversible) to lethal (and hence irreversible) injury, unless protective procedures are introduced.
The no-reflow phenomenon. Before considering future trends in this field and ways of protecting potentially viable cells against further damage on reperfusion, some mention should be made of what has become known as the no-reflow phenomenon. This is the patchy reperfusion that occurs when perfusion buffer is reintroduced to the coronary circulation after prolonged periods of ischemia under nonisovolumetric conditions. It is due to capillary "shut down" and occurs not because of thrombosis but rather because osmotic swelling of the cardiac myocytes or tissue edema physically constricts the capillaries. 25 The area of noreflow increases with the duration of reperfusion. However, since isovolumetric distention during the ischemic episode prevents its occurrence, the underlying cause of the phenomenon belongs to the ischemic rather than the reperfusion phase.
Although well documented in isolated hearts the relevance of the no-reflow phenomenon under conditions in vivo is not known.
The future. After an ischemic episode in vivo, the cardiac myocytes exhibit a spectrum of damage. Some cells are unaffected, since the blood flow to them has not been compromised. Others are lethally injured, and therefore cannot be recovered. Between these two extremes (from zero to total damage) are a number of damaged, but as yet nonlethally injured cells that reperfusion can either salvage or destroy. Without reperfusion, however, they will all die. It is crucial, therefore, that conditions of reperfusion be established that will result in the maximal salvage of these cells.
Experiments that are aimed at establishing optimal conditions of reperfusion can be performed on preparations in vitro in which the required spectrum of damage can be produced by varying the duration of the ischemic episode. There is a need, however, for a biochemical and/or morphologic marker that can be used to distinguish those cells already lethally injured by the ischemic episode from those that are not. Such a marker would facilitate the separation of those cells for which reperfusion can only result in the expression of the preexisting lethal damage from those for which it may be beneficial if the conditions of reperfusion are controlled. Comparatively little attention has been given to date to interventions that, if applied at the time of reperfusion, would improve functional recovery and decrease damage. It is essential that such interventions be established, because in the clinical situation, ischemia can be neither predicted nor planned. There is an urgent need, therefore, for a protocol to be developed to ensure that the potentially salvageable tissue is protected from further damage on reperfusion. 29 Here there appears to be a dilemma. The heart is an aerobic organ with comparatively little capacity for anaerobic metabolism. Obviously, therefore, the reperfusion buffer must not only contain the necessary precursors for nucleotide production, but oxygen must also be readmitted. Restoring the oxygen supply, however, carries with it the attendant risk of free-radical formation and hence of membrane damage and disruption due to lipid peroxidation. Clearly, therefore, the generation of superoxide anions should be controlled, a conclusion that is supported by a number of recent laboratory studies.21 22 Even if this is achieved there is no guarantee that Cat + overloading will not occur when potentially salvageable cells are reperfused. Unless the energyrich phosphate reserves are replenished, even the entry of Cat+ through normal physiologic pathways will ultimately precipitate a Catt overload situation, causing in turn the activation of destructive, Ca++-sensitive proteases and phospholipases that almost certainly will destroy membrane integrity.
In conclusion, if an uncontrolled gain in Cat + is the ultimate cause of cell death, then whether reperfusion lethally damages or benefits potentially salvageable tissue must depend finally on the preservation of membrane integrity and the replenishment of the endogenous energy-rich phosphate reserves. Preservation of membrane integrity involves maintenance of osmotic control, prevention of free-radical accumulation, and maintenance of Ca+ + homeostasis. Preservation of the energy-rich phosphates involves maintenance of the relevant precursors. If these conditions can be satisfied then the reperfusion of potentially salvageable and hence nonlethally injured tissue need not exacerbate the damage caused by the preceding ischemic episode, because an excessive accumulation of Cat t will not occur. The solution to these problems requires data from two sources -the animal laboratory and the clinic. Once the information is available then the conditions under which reperfusion will be beneficial rather than deleterious will have been established and the dilemma solved.
